• Globe Newswire

Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France

Globenewswire -

• Globe Newswire

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe

• Globe Newswire

Sandoz reports first quarter 2024 sales

• Globe Newswire

Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG

• Globe Newswire

Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs

• Globe Newswire

Sandoz announces changes in the Board of Directors